Paragonix Technologies, Inc., a leader in organ transplant innovations, has unveiled its annual report from the GUARDIAN-Heart Clinical Registry at the 44th ISHLT Annual Meeting and Scientific Sessions. This groundbreaking study marks the first instance where a medical device has…
CND Life Sciences (CND) has made a significant announcement regarding the presentation of six abstracts related to the identification of phosphorylated alpha-synuclein (P-SYN) in cutaneous nerve fibers in the skin at the American Academy of Neurology 2024 Annual Meeting (AAN).…
Antech, a leading veterinary diagnostics company dedicated to collaborating with veterinary professionals in predicting, diagnosing, and monitoring wellness and disease, has introduced two groundbreaking innovations that signify a new era in veterinary diagnostics. These innovations, AIS RapidRead for accelerated radiograph…
Coastal Medical Transportation Systems (CMTS), a leading medical transportation company committed to delivering exceptional care with compassion, dignity, and respect, announces its continued support for the 128th Boston Marathon Medical Deployment on April 15, 2024. Partnering with state public safety…
GE HealthCare (Nasdaq: GEHC), a pioneer in breast health technology and diagnostics, will unveil its newest breast cancer detection advancements at the 2024 Society of Breast Imaging Symposium in Montreal, Canada, from April 11-14, 2024. The showcase will spotlight the…
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical firm focused on innovative treatments for spinal muscular atrophy and other serious conditions, announced granting inducement equity awards to two new employees. These awards consist of stock options for 25,714 shares and restricted…
The latest addition to ResearchAndMarkets.com’s offerings: Global Research Antibodies & Reagents Market Forecast 2024-2029. The Global Research Antibodies & Reagents Market witnessed a valuation of USD 13.39 billion in 2023, with projections to reach USD 21.28 billion by 2029, marking…
Today, TheracosBio announced the publication of a study in the Journal of Diabetes titled “Comparison of Bexagliflozin with Dapagliflozin as an Adjunct to Metformin in Chinese Patients with Type 2 Diabetes Mellitus: A 24-week Phase 3 Trial.” The study, conducted…
Today, HeartBeam, Inc. (NASDAQ: BEAT), a medical technology firm dedicated to revolutionizing cardiac care with personalized insights, revealed new findings indicating significant improvements in atrial flutter detection by employing the company’s artificial intelligence (AI) algorithms on vectorcardiography (VCG). The results…
Today marks the launch of the Collective Healthcare Action to Reduce MedTech Emissions (CHARME) collaborative, aiming to slash greenhouse gas emissions from the U.S. medical device and equipment supply chain. The MedTech supply chain contributes to 7% of U.S. healthcare…
Today, InfoBionic.Ai, a digital health firm offering AI-driven diagnostic remote patient monitoring solutions, announced a name change from ‘InfoBionic’ to ‘InfoBionic.Ai.’ This shift underscores the company’s ongoing dedication to harnessing artificial intelligence in virtual cardiac care. InfoBionic has long been…
S2 Genomics, a leading innovator in tissue sample preparation systems, has unveiled its latest groundbreaking product, the Singulator™ 200+ System. This state-of-the-art technology represents a significant advancement in automated sample preparation specifically designed for single-cell formalin-fixed, paraffin-embedded (FFPE) tissues. By…